🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The blood brain barrier (BBB) prevents some drugs from successfully reachin...
Status
Recruiting
Location
Columbia University Irving Medical Center
Start Date
2023-06-05
Trial ID
NCT05762419
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
This study aims to investigate the efficacy and safety of PET regimen combi...
Status
Unknown
Location
The Affiliated Hospital of Qingdao University
Start Date
2017-03-01
Trial ID
NCT03273452
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
Based on data supporting the use of cyclophosphamide and etoposide both as ...
Status
Completed
Location
Central Jersey Oncology Center
Start Date
2005-05
Trial ID
NCT00176605
Treatments Being Tested
This phase II trial studies the effect of lamivudine in combination with st...
Status
Recruiting
Location
Roswell Park Cancer Institute
Start Date
2021-07-02
Trial ID
NCT04696575
Treatments Being Tested
This study is a prospective open-label, single-arm, single-center clinical ...
Status
Recruiting
Location
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2023-06-21
Trial ID
NCT05747729
Treatments Being Tested
This study is trying to evaluate the efficacy and safety of dose-modified E...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2025-06-01
Trial ID
NCT06951971
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130
This is a phase II/III randomized controlled trial to evaluate efficacy of ...
Status
Unknown
Location
N.N. Blokhin Cancer Research Center
Start Date
2019-09-01
Trial ID
NCT04055038
Treatments Being Tested